George S Alexopoulos1, Jo Anne Sirey2, Samprit Banerjee2, Danielle S Jackson2, Dimitris N Kiosses2, Cristina Pollari2, Richard S Novitch3, Amanda Artis4, Patrick J Raue5. 1. Institute for Geriatric Psychiatry, Weill Cornell Medicine, White Plains, NY. Electronic address: gsalexop@med.cornell.edu. 2. Institute for Geriatric Psychiatry, Weill Cornell Medicine, White Plains, NY. 3. Burke Rehabilitation Hospital, White Plains, NY. 4. Department of Healthcare Policy & Research, Weill Cornell Medicine, New York, NY. 5. Department of Psychiatry & Behavioral Sciences, University of Washington School of Medicine, Seattle, WA.
Abstract
OBJECTIVE: The Personalized Intervention for Depressed Patients with Chronic Obstructive Pulmonary Disease (PID-C) is an intervention aiming to help patients adhere to their rehabilitation and care. This study tested the hypothesis that the Problem-Solving Adherence (PSA) intervention, which integrates problem-solving into adherence enhancement procedures, reduces dyspnea-related disability more than PID-C. Exploratory analyses sought to identify patients with distinct dyspnea-related disability trajectories and to compare their clinical profiles. METHODS: In this randomized controlled trial in an acute inpatient rehabilitation and community, 101 participants diagnosed with chronic obstructive pulmonary disease (COPD) and major depression were included after screening 633 consecutive admissions for acute inpatient rehabilitation. Participants underwent 14 sessions of PID-C versus PSA over 26 weeks using the Pulmonary Functional Status and Dyspnea Questionnaire. RESULTS: The study hypothesis was not supported. Exploratory latent class growth modeling identified two distinct disability trajectories. Dyspnea-related disability improved in 39% of patients and remained unchanged in the rest. Patients whose dyspnea-related disability improved had more severe disability and less sense of control over their condition at baseline. CONCLUSION:Improvement or no worsening of disability was noted in both treatment groups. This is a favorable course for depressed patients with a severe, deteriorating medical illness. PID-C is compatible with the expertise of clinicians working in community-based rehabilitation programs, and after further testing in the community, it can be integrated in the care of depressed COPD patients.
RCT Entities:
OBJECTIVE: The Personalized Intervention for DepressedPatients with Chronic Obstructive Pulmonary Disease (PID-C) is an intervention aiming to help patients adhere to their rehabilitation and care. This study tested the hypothesis that the Problem-Solving Adherence (PSA) intervention, which integrates problem-solving into adherence enhancement procedures, reduces dyspnea-related disability more than PID-C. Exploratory analyses sought to identify patients with distinct dyspnea-related disability trajectories and to compare their clinical profiles. METHODS: In this randomized controlled trial in an acute inpatient rehabilitation and community, 101 participants diagnosed with chronic obstructive pulmonary disease (COPD) and major depression were included after screening 633 consecutive admissions for acute inpatient rehabilitation. Participants underwent 14 sessions of PID-C versus PSA over 26 weeks using the Pulmonary Functional Status and Dyspnea Questionnaire. RESULTS: The study hypothesis was not supported. Exploratory latent class growth modeling identified two distinct disability trajectories. Dyspnea-related disability improved in 39% of patients and remained unchanged in the rest. Patients whose dyspnea-related disability improved had more severe disability and less sense of control over their condition at baseline. CONCLUSION: Improvement or no worsening of disability was noted in both treatment groups. This is a favorable course for depressedpatients with a severe, deteriorating medical illness. PID-C is compatible with the expertise of clinicians working in community-based rehabilitation programs, and after further testing in the community, it can be integrated in the care of depressed COPDpatients.
Authors: George S Alexopoulos; Patrick J Raue; Dimitris N Kiosses; R Scott Mackin; Dora Kanellopoulos; Charles McCulloch; Patricia A Areán Journal: Arch Gen Psychiatry Date: 2011-01
Authors: George S Alexopoulos; Jo Anne Sirey; Samprit Banerjee; Dimitris N Kiosses; Cristina Pollari; Richard S Novitch; Amanda Artis; Patrick J Raue Journal: Am J Geriatr Psychiatry Date: 2016-07-20 Impact factor: 4.105
Authors: Pim Cuijpers; Nicole Vogelzangs; Jos Twisk; Annet Kleiboer; Juan Li; Brenda W Penninx Journal: Am J Psychiatry Date: 2014-04 Impact factor: 18.112
Authors: George S Alexopoulos; Dimitris N Kiosses; Jo Anne Sirey; Dora Kanellopoulos; Richard S Novitch; Samiran Ghosh; Joanna K Seirup; Patrick J Raue Journal: Br J Psychiatry Date: 2013-02-07 Impact factor: 9.319
Authors: Danielle S Jackson; Samprit Banerjee; Jo Anne Sirey; Cristina Pollari; Nili Solomonov; Richard Novitch; Alexandra Chalfin; Yiyuan Wu; George S Alexopoulos Journal: Am J Geriatr Psychiatry Date: 2018-12-07 Impact factor: 4.105
Authors: Natalie C Benda; George S Alexopoulos; Patricia Marino; Jo Anne Sirey; Dimitris Kiosses; Jessica S Ancker Journal: AMIA Annu Symp Proc Date: 2021-01-25
Authors: Nili Solomonov; Jihui Lee; Samprit Banerjee; Christoph Flückiger; Dora Kanellopoulos; Faith M Gunning; Jo Anne Sirey; Conor Liston; Patrick J Raue; Thomas D Hull; Patricia A Areán; George S Alexopoulos Journal: Mol Psychiatry Date: 2020-07-10 Impact factor: 15.992